Reglan, or metoclopramide hydrochloride, is prescribed to treat symptoms of certain gastrointestinal disorders such as diabetic gastroparesis, a condition in which the stomach is unable to contract. Reglan is also used on a short term basis to treat heartburn associated with gastroesophageal reflux disorder and is used to prevent nausea associated with chemotherapy and surgery.
Raglan works by stimulating muscular contractions in the upper digestive system, causing the stomach to more effectively empty its contents into the small intestine. Metoclopramide drugs such as Reglan are not recommended for long-term use and have been associated with side-effects such as:
Reglan linked to tardive dyskinesia
On Feb. 26, 2009 the FDA issued a black box warning for metoclopramide-containing drugs such as Reglan after long-term use of the drug was found to cause tardive dyskinesia, a condition characterized by involuntary, spasmodic movements primarily in the mouth, tongue and jaw. The condition may also cause involuntary pursing of the lips, rapid blinking, grimacing and rapid eye movement. Tardive dyskinesia is rarely reversible, but in some cases conditions have been found to decrease after the use of metaclopramide is stopped.
Currently, over two million Americans take metoclopramide-containing products such as Reglan Tablets, Metoclopramide Oral Solution, and Reglan Injection. If you are currently taking Reglan and have experienced symptoms of tardive dyskinesia, please contact your doctor immediately.
Contact Bailey & Galyen Pharmaceutical Attorneys
If you or a loved one has developed tardive dyskinesia or have suffered serious side-effects from the use of Reglan, you may be entitled to recover for lost wages, medical bills or pain and suffering. Contact the pharmaceutical attorneys at Bailey & Galyen today to discuss your case.